Because patients with moderate uric acid excretion but fixed low urine pH can form uric acid stones, it appears that reducing uric acid excretion with xanthine oxidase/dehydrogenase inhibitors (allopurinol and febuxostat) without increasing urine pH will ultimately not be as successful as alkalinization [11]. The gene discussed is XDH; the disease is Uric acid nephrolithiasis.